This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study design
This was a randomised controlled trial, conducted in two federally subsidised apartment complexes for older adults in the area of Los Angeles in California. Randomisation was based on computer-generated random numbers and a blocking factor of 6. Subjects in the study were assessed after the treatment period of nine months (post-test assessment) and after a six-month follow-up (follow-up assessment). Follow-up data were available for 47 of the 51 subjects in the OT group, 47 of the 53 subjects in the active control group, and 54 of the 59 subjects in the passive control group. Study therapists were blind to the study hypothesis.
Analysis of effectiveness
The analysis of the clinical study was based on intention to treat. In the original study several outcome measures were assessed, whilst in the present study the primary health outcome was the patient quality of life index associated with each treatment, assessed using the RAND SF-36 instrument, which provided quality of life information based on responder's recall of functioning during previous months. Study groups were shown to be comparable at baseline in terms of demographics and clinical characteristics.
Effectiveness results
The results of the SF-36 quality of life assessment were not reported. The authors reported that, after the treatment, the analysis showed a statistically significant improvement in terms of quality of life, favouring the OT group. "Approximately 90% of the therapeutic gain observed after OT treatment was retained in follow-up, in the absence of further intervention".
Clinical conclusions
It appears that the OT treatment was effective in improving quality of life in independent-living elderly people.
Measure of benefits used in the economic analysis
The benefit measure used in the economic analysis was quality-adjusted life-years (QALYs), which were calculated using an established formula and assuming that quality of life measures remained stable for 6-months. Utility weights were derived from quality of life scores calculated using the SF-36 method and converted to Health Utility Index (HUI). HUIs were adjusted for planned covariates, such as gender, age group, disability status, Mini-Mental Status examination, and living status.
Direct costs
A 3% discount rate was used to calculate annualised costs (even though the time horizon of the study was shorter than two years). Unit costs and quantities of resources were reported separately only for some items. The economic analysis included the programme costs, healthcare costs (physician office visits, health-professional home visits, hospital outpatient services, and hospital overnight stays), and caregiver costs (paid and unpaid in-home support). The cost/resource boundary adopted appears to have been that of the third party payer. The estimation of costs was based Although the authors stated that the study was conducted from a societal perspective, it seems that only costs relevant to the reimbursement authority were included in the analysis. It is possible, as acknowledged in the paper, that the approach used in the study underestimated commercial charges for medical services and professional caregivers. Standard statistical analyses were conducted to assess for statistical significance of total costs. The price year was reported. However, unit costs were reported separately from quantities of resources only for certain cost items. Costs were specific to the study setting and no sensitivity analyses were conducted. As total costs were not statistically significantly different across the study groups, the authors assumed that medical costs were the same for each treatment group. The authors acknowledged that the lack of statistical significance was caused by the large variability of healthcare costs and the limited sample size in the OT group.
